NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Monday that fiscal second-quarter revenues rose 3 percent year over year while revenues for its Life Sciences segment increased 1 percent.

Total revenues for the three months ended April 30 increased to $1.73 billion from $1.68 billion a year ago, beating Wall Street estimates of $1.71 billion. Total orders increased 8 percent to $1.84 billion during the quarter from $1.70 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.